230 related articles for article (PubMed ID: 30737061)
1. Association of renin-angiotensin system inhibitors with long-term outcomes in patients with systolic heart failure and moderate-to-severe kidney function impairment.
Higuchi S; Kohsaka S; Shiraishi Y; Katsuki T; Nagatomo Y; Mizuno A; Sujino Y; Kohno T; Goda A; Yoshikawa T;
Eur J Intern Med; 2019 Apr; 62():58-66. PubMed ID: 30737061
[TBL] [Abstract][Full Text] [Related]
2. Renin-angiotensin inhibition in systolic heart failure and chronic kidney disease.
Ahmed A; Fonarow GC; Zhang Y; Sanders PW; Allman RM; Arnett DK; Feller MA; Love TE; Aban IB; Levesque R; Ekundayo OJ; Dell'Italia LJ; Bakris GL; Rich MW
Am J Med; 2012 Apr; 125(4):399-410. PubMed ID: 22321760
[TBL] [Abstract][Full Text] [Related]
3. Association between use of renin-angiotensin system antagonists and mortality in patients with heart failure and preserved ejection fraction.
Lund LH; Benson L; Dahlström U; Edner M
JAMA; 2012 Nov; 308(20):2108-17. PubMed ID: 23188027
[TBL] [Abstract][Full Text] [Related]
4. Association between renin-angiotensin system antagonist use and mortality in heart failure with severe renal insufficiency: a prospective propensity score-matched cohort study.
Edner M; Benson L; Dahlström U; Lund LH
Eur Heart J; 2015 Sep; 36(34):2318-26. PubMed ID: 26069212
[TBL] [Abstract][Full Text] [Related]
5. Comparative Effectiveness of Renin-Angiotensin System Inhibitors and Calcium Channel Blockers in Individuals With Advanced CKD: A Nationwide Observational Cohort Study.
Fu EL; Clase CM; Evans M; Lindholm B; Rotmans JI; Dekker FW; van Diepen M; Carrero JJ
Am J Kidney Dis; 2021 May; 77(5):719-729.e1. PubMed ID: 33246024
[TBL] [Abstract][Full Text] [Related]
6. The association of chronic kidney disease with the use of renin-angiotensin system inhibitors after acute myocardial infarction.
Wetmore JB; Tang F; Sharma A; Jones PG; Spertus JA
Am Heart J; 2015 Oct; 170(4):735-43. PubMed ID: 26386797
[TBL] [Abstract][Full Text] [Related]
7. Trends in Kidney Function Outcomes Following RAAS Inhibition in Patients With Heart Failure With Reduced Ejection Fraction.
McCallum W; Tighiouart H; Ku E; Salem D; Sarnak MJ
Am J Kidney Dis; 2020 Jan; 75(1):21-29. PubMed ID: 31303349
[TBL] [Abstract][Full Text] [Related]
8. Renin-angiotensin system inhibitors for patients with mild or moderate chronic kidney disease and heart failure with mildly reduced or preserved ejection fraction.
Takeuchi S; Kohno T; Goda A; Shiraishi Y; Kitamura M; Nagatomo Y; Takei M; Nomoto M; Soejima K; Kohsaka S; Yoshikawa T;
Int J Cardiol; 2024 Aug; 409():132190. PubMed ID: 38761975
[TBL] [Abstract][Full Text] [Related]
9. Trends in the Use of Guideline-Directed Therapies Among Dialysis Patients Hospitalized With Systolic Heart Failure: Findings From the American Heart Association Get With The Guidelines-Heart Failure Program.
Pandey A; Golwala H; DeVore AD; Lu D; Madden G; Bhatt DL; Schulte PJ; Heidenreich PA; Yancy CW; Hernandez AF; Fonarow GC
JACC Heart Fail; 2016 Aug; 4(8):649-61. PubMed ID: 27179827
[TBL] [Abstract][Full Text] [Related]
10. Treatment with Optimal Dose Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Has a Positive Effect on Long-Term Survival in Older Individuals (Aged >70 Years) and Octogenarians with Systolic Heart Failure.
Sargento L; Simões AV; Longo S; Lousada N; Dos Reis RP
Drugs Aging; 2016 Sep; 33(9):675-83. PubMed ID: 27568454
[TBL] [Abstract][Full Text] [Related]
11. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN
Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651
[TBL] [Abstract][Full Text] [Related]
12. Association of Renin-Angiotensin Inhibitor Treatment With Mortality and Heart Failure Readmission in Patients With Transcatheter Aortic Valve Replacement.
Inohara T; Manandhar P; Kosinski AS; Matsouaka RA; Kohsaka S; Mentz RJ; Thourani VH; Carroll JD; Kirtane AJ; Bavaria JE; Cohen DJ; Kiefer TL; Gaca JG; Kapadia SR; Peterson ED; Vemulapalli S
JAMA; 2018 Dec; 320(21):2231-2241. PubMed ID: 30512100
[TBL] [Abstract][Full Text] [Related]
13. Evidence-Based Medical Therapy in Patients With Heart Failure With Reduced Ejection Fraction and Chronic Kidney Disease.
Beldhuis IE; Lam CSP; Testani JM; Voors AA; Van Spall HGC; Ter Maaten JM; Damman K
Circulation; 2022 Mar; 145(9):693-712. PubMed ID: 35226558
[TBL] [Abstract][Full Text] [Related]
14. Detrimental effect of renin-angiotensin blockade on progression of chronic kidney disease at later stages: A matter of dosage adjustment?
Caravaca-Fontán F; Valladares J; Díaz-Campillejo R; Barroso S; Luna E; Caravaca F
Nefrologia (Engl Ed); 2020; 40(1):38-45. PubMed ID: 31196659
[TBL] [Abstract][Full Text] [Related]
15. Use of Renin-Angiotensin System Blockade in Advanced CKD: An NKF-KDOQI Controversies Report.
Weir MR; Lakkis JI; Jaar B; Rocco MV; Choi MJ; Kramer HJ; Ku E
Am J Kidney Dis; 2018 Dec; 72(6):873-884. PubMed ID: 30201547
[TBL] [Abstract][Full Text] [Related]
16. Association Between Renin-Angiotensin System Blockade Discontinuation and All-Cause Mortality Among Persons With Low Estimated Glomerular Filtration Rate.
Qiao Y; Shin JI; Chen TK; Inker LA; Coresh J; Alexander GC; Jackson JW; Chang AR; Grams ME
JAMA Intern Med; 2020 May; 180(5):718-726. PubMed ID: 32150237
[TBL] [Abstract][Full Text] [Related]
17. Renin-Angiotensin System Inhibitors and Kidney and Cardiovascular Outcomes in Patients With CKD: A Bayesian Network Meta-analysis of Randomized Clinical Trials.
Xie X; Liu Y; Perkovic V; Li X; Ninomiya T; Hou W; Zhao N; Liu L; Lv J; Zhang H; Wang H
Am J Kidney Dis; 2016 May; 67(5):728-41. PubMed ID: 26597926
[TBL] [Abstract][Full Text] [Related]
18. Underprescription of renin-angiotensin system blockers in moderate to severe chronic kidney disease.
Shirazian S; Grant CD; Mujeeb S; Sharif S; Kumari P; Bhagat M; Mattana J
Am J Med Sci; 2015 Jun; 349(6):510-5. PubMed ID: 26030613
[TBL] [Abstract][Full Text] [Related]
19. The Impact of Renin-Angiotensin System Blockade on Renal Outcomes and Mortality in Pre-Dialysis Patients with Advanced Chronic Kidney Disease.
Oh YJ; Kim SM; Shin BC; Kim HL; Chung JH; Kim AJ; Ro H; Chang JH; Lee HH; Chung W; Lee C; Jung JY
PLoS One; 2017; 12(1):e0170874. PubMed ID: 28122064
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of renin-angiotensin system inhibitors for patients with heart failure with preserved ejection fraction and mild to moderate chronic kidney disease.
Tsujimoto T; Kajio H
Eur J Prev Cardiol; 2018 Aug; 25(12):1268-1277. PubMed ID: 29808753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]